Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Mirion Technologies Inc. Class A

Mirrabooka Investments Ltd ( ($AU:MIR) ) has issued an announcement. Mirrabooka Investments Limited has outlined its key corporate and dividend tim...

Mirrabooka Sets 2026 Timetable for Results, Dividends and AGM

An update from MIRA Pharmaceuticals, Inc. ( ($MIRA) ) is now available. On June 17, 2026, MIRA Pharmaceuticals announced it had submitted a Phase 2...

MIRA Advances Ketamir-2 Into FDA-Accepted Phase 2a Trial

Mirrabooka Investments Ltd ( ($AU:MIR) ) just unveiled an update. Mirrabooka Investments Limited has reported an estimated unaudited pre-tax net ta...

Mirrabooka posts estimated pre-tax NTA of $2.76 per share

MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has issued an announcement. On June 6, 2026, MIRA Pharmaceuticals, Inc. implemented a leadership change in i...

MIRA Pharmaceuticals Appoints New Fractional Chief Financial Officer

An update from Mirrabooka Investments Ltd ( ($AU:MIR) ) is now available. Mirrabooka Investments reported a slight decline in its net tangible asse...

Mirrabooka NTA Edges Lower as Small and Mid-Cap Portfolio Holds Course

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Legend Biotech (LEGN), Tempus AI, Inc. Class A (TE...

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Tempus AI, Inc. Class A (TEM) and Mirum Pharmaceuticals (MIRM)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zevra Therapeutics (ZVRA), Fate Therapeutics (FATE) ...

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Fate Therapeutics (FATE) and Mirum Pharmaceuticals (MIRM)

Mirrabooka Investments Ltd ( ($AU:MIR) ) has issued an update. Mirrabooka Investments Limited has released an updated estimate of its pre-tax net t...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MIR	$19.12	+3.13%	1.54M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MIR	$19.12	+3.1%	1.54M
3
4
5
6

MIR

MIR

Compare Stocks

Start Your Comparison

Get Mirion Technologies Inc. Class A Data in Excel

Get Mirion Technologies Inc. Class A Data in Excel